SPONSOR

Peking University People's Hospital

Total Trials

Recruiting

Phases

Phase 1, Phase 2, Phase 2, Phase 1, Phase 4

Conditions studied: Relapsing Polychondritis End Stage Renal Disease on Dialysis AML (Acute Myeloid Leukemia)Primary Angle-closure Glaucoma Acute Myeloid Leukemia AML Refractory/Relapse Acute Myeloid Leukemia Critical Care Medicine Mortality Prediction Persistent Thrombocytopenia

Peking University People's Hospital is a clinical research sponsor with 23 registered studies on ClinicalTrials.gov, of which 23 are actively recruiting participants. Research covers conditions including Relapsing Polychondritis, End Stage Renal Disease on Dialysis, AML (Acute Myeloid Leukemia), Primary Angle-closure Glaucoma.

The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Peking University People's Hospital

How many clinical trials has Peking University People's Hospital sponsored?

ClinicalMetric currently tracks 23 clinical trials sponsored by Peking University People's Hospital, of which 23 are actively recruiting participants. These trials cover conditions including Relapsing Polychondritis, End Stage Renal Disease on Dialysis, AML (Acute Myeloid Leukemia). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Peking University People's Hospital research focus on?

Peking University People's Hospital clinical trials span Relapsing Polychondritis, End Stage Renal Disease on Dialysis, AML (Acute Myeloid Leukemia), Primary Angle-closure Glaucoma, Acute Myeloid Leukemia, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Peking University People's Hospital clinical trial?

To participate in a Peking University People's Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking University People's Hospital trials with current recruitment status updated daily.

Peking University People's Hospital

Frequently Asked Questions — Peking University People's Hospital

Clinical Trials by Peking University People's Hospital

Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis

Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease

Interferon-α Maintenance in Favorable-Risk AML

Kahook Dual Blade Goniotomy in Chronic Primary Angle-Closure Glaucoma

MRD Response-adapted Allo-HSCT for Adverse-risk AML

Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML

Clinical Validation of a Pre-trained and Fine-tuned Model for Analyzing Time-Series Electronic Health Records in Critical Care

Baricitinib for Post-HSCT Persistent Thrombocytopenia

Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Frontline of ASCT in High-risk DLBCL

The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP

Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT

Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer: an Open, Single Arm, Multicenter Study

Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia

A Prediction Model in Pregnant Women With Aplastic Anemia

Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment

Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Longitudinal Cohort of Thrombosis and Hemostasis Diseases